UNSPSC 51181625: Calcitonin salmon

This classification denotes a peptide hormone with the molecular formula C145H240N44O48S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7SFC6U2VI5, chemically known as calcitonin (salmon) [ep], but more generally known as calcitonin salmon, which bears US NIH Compound Identifier 16129616. European Medicines Agency schedules calcitonin salmon or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00948MIG. Most nations, for tariff purposes, schedule calcitonin salmon under HS 29371900. SMILES:.

Calcitonin salmon bears US NLM identifiers UMLS ID C0073994 and NCI Concept Code C329.

UNSPSC 51181625 Calcitonin salmon, a Commodity code, covers pharmaceutical products derived from salmon calcitonin — a synthetic or naturally derived hormone used primarily to treat osteoporosis, hypercalcemia, and Paget's disease. State and local governments procure calcitonin salmon primarily through Medicaid pharmacy benefit programs, state health departments managing employee benefits, and public health agencies supporting institutional and outpatient care. The code encompasses calcitonin salmon in all approved dosage forms and delivery routes, including injectable and intranasal formulations. Issuing bodies include state Medicaid agencies, departments of health and human services, state employee health benefit offices, county health systems, and public hospitals and clinics.

The source provides no records of recent state or local contract opportunities under this code, limiting visibility into current geographic activity and issuing-body patterns. Without posted solicitations, RFPs, RFQs, or ITBs naming this code, the procurement landscape for calcitonin salmon at the state and local level cannot be characterized by region, contracting frequency, or representative opportunity detail at this time.